Progression difference between cancers of the larynx and hypopharynx is not due to tumor size and vascularization

Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 1, 2001, Pages 18-22

  Lukits, J ^b   Timar J ^a   Juhasz A ^d   Dome B ^a,b   Paku, S ^e   Repassy G ^c  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b Experimental Cancer Research   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; CANCER STAGING; COMPARATIVE STUDY; CULTURE TECHNIQUE; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; HYPOPHARYNX; HYPOPHARYNX TUMOR; IMMUNOHISTOCHEMISTRY; LARYNX; LARYNX TUMOR; MALE; MORTALITY; NEEDLE BIOPSY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROBABILITY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; SURVIVAL; VASCULARIZATION;

ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CULTURE TECHNIQUES; DISEASE PROGRESSION; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; HYPOPHARYNX; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LARYNX; MALE; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROBABILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0035403281     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2001.116187     Document Type: Article

References (18)

1. Hoffman HT, Karnell LH, Funk GF, et al. The National Cancer Data Base Report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:951-62.
2. Sessions RB, Harrison LB, Forastiere AA. Cancers of the larynx and hypopharynx. In: De Vita VT, Hellman S, Rosenberg SA, editors. Cancer, principles and practice of oncology. 5th ed. New York: Lippincott-Raven; 1997. p. 808-29.
3. Maurizi M, Almadori G, Ferrandina G, et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 1996;74:1253-7.
4. Welkoborsky HJ, Hinni M, Dienes HP, et al. Predicting recurrence and survival in patients with laryngeal cancer by means of DNA cytometry, tumor front grading and proliferation markers. Ann Otol Rhinol Laryngol 1995;104:503-10.
5. Piffkó J, Bánkfalvy Á, Öfner D, et al. Proliferative (MIB1,mdm2) versus anti-proliferative (p53) markers in head and neck cancer. An immunohistochemical study. Pathol Oncol Res 1996;2:37-42.
6. Tamás L, Sziklai I, Ribári O. Diagnostic value of tumor markers in ENT oncology. Orvosi Hetilap 1997;138:1261-4.
7. Spafford MF, Koeppe J, Pan Z, et al. Correlation of tumor markers p53, bcl2, CD34, CD44H,CD44v6 and ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1996;122:627-32.
8. Zetter BR. Angiogenesis and tumor metastasis. Ann Rev Med 1998;49:407-24.
9. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumors: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474-84.
10. Murray JD, Carlson GW, McLaughlin K, et al. Tumor angiogenesis as a prognostic factor in laryngeal cancer. Am J Surg 1997;174:523-6.
11. Beatrice F, Cammarota R, Giordano C, et al. Angiogenesis: prognostic significance in laryngeal cancer. Anticancer Res 1998;18:4737-40.
12. Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Canc Inst 1998;90:587-96.
13. Paku S, Lapis K. Morphometrical aspects of angiogenesis in experimental liver metastases. Am J Pathol 1993;143:926-36.
14. Lydiatt WM, Schantz SP. Biological staging of neck cancer and its role in developing effective treatment strategies. Cancer Metast Rev 1996;15:11-25.
15. Papadimitrakopoulou VA, Shin DM, Hong WK. Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis. Cancer Metast Rev 1996;15:53-76.
16. McDonalds JS, Gartside PS, Pavelic LJ. NM23-H1 expression in squamous cell carcinoma of the head and neck. Pathol Oncol Res 1996;2:34-6.
17. Répássy G, Foster-Horváth Cs, Juhász A, et al. Expression of invasion markers CD44v6/v3, Nm23 and MMP-2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res 1998;4:14-21.
18. Khokha R, Dedhardt DT. Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metast 1989;9:391-405.